Asimov
Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided design and machine learning to program living cells and optimize therapeutic candidates. Its platform uses AI-driven predictive models and CAD-style design workflows to accelerate biological design cycles for research teams, biotechs, and contract developers. Asimov operates in the B2B life sciences software and tools market focused on next-generation therapeutics.
Asimov
Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided design and machine learning to program living cells and optimize therapeutic candidates. Its platform uses AI-driven predictive models and CAD-style design workflows to accelerate biological design cycles for research teams, biotechs, and contract developers. Asimov operates in the B2B life sciences software and tools market focused on next-generation therapeutics.
